CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES

Volume: 04 Issue: 03 | May-Jun 2023 ISSN: 2660-4159

http://cajmns.centralasianstudies.org

Stem Cell Therapy for Alzheimer’s Disease Treatment

1. Supriya Chaudhary Abstract: Stem cell therapy is a unique approach to
treating Alzheimer’s Disease. It involves the systemic
introduction of Mesenchymal Stem Cells into the body
Received 2nd Mar 2023,
via IV. When introduced in large quantities, these stem
Accepted 3rd Apr 2023, cells can find inflammation within the body and repair
Online 19th May 2023 it. This unique property of stem cells is what potentially
makes them a viable treatment for Alzheimer’s Disease.
1
Alzheimer's disease, a form of dementia that affects
Agra, Uttar Pradesh, India memory, thinking, and behavior, is a growing public
health concern. According to the Alzheimer's
Association, an estimated 6.2 million Americans are
living with Alzheimer's, and this is projected to rise to
nearly 14 million by 2050. One of the hallmarks of
Alzheimer's disease is the presence of amyloid protein
deposits in the brain. While current Alzheimer's
treatments, including anti-anxiety drugs, aim to treat the
symptoms of moderate Alzheimer's, there is a need for
more effective treatments that can slow or halt the
progression of the disease. In recent years, stem cell
therapy has emerged as a promising potential treatment
for Alzheimer's, and several clinical trials are underway
to determine the safety and efficacy of this approach.
Key words: stem cell therapy, Alzheimer’s disease,
dementia, amyloid protein, anti-anxiety drugs, clinical
trials.

Introduction
Stem cell therapy for Alzheimers is a unique approach to treating Alzheimer’s Disease. It involves the
systemic introduction of Mesenchymal Stem Cells into the body via intravenous injection IV. When
introduced in large quantities, these stem cells can find and repair inflammation within the body. This
unique property of stem cells potentially makes them a viable treatment for Alzheimer’s Disease. Stem
cell therapy for Alzheimer's may be able to:
1. Improve functional memory
2. Regenerate neurons
3. Improve overall functional recovery
4. Replace damaged cells with healthy cells[1]

1079 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
CAJMNS Volume: 04 Issue: 03 | May-Jun 2023
Clinical trial considerations
According to Lawrence Goldstein, Ph.D., The increased amount of plaques and tangles within the
brain of an Alzheimer’s patient affects two essential proteins: ‘amyloid-beta’ and ‘tau.’ (2) Stem cell
treatment for Alzheimer's Disease aims to replace damaged cells with healthy stem cells that can grow
on their own, creating new healthy brain cells.
Research shows exciting results
Research suggests stem cell therapy may improve brain health by reducing swelling, repairing
damaged nerve cells, and improving cognitive function in people with mild to severe Alzheimer's
disease and other related dementias.
Mesenchymal stem cells (MSCs), in particular, have been found to both support the immune system
and reduce inflammation. According to a 2020 study, MSCs may suppress inflammation processes in
different ways, through the upregulation of anti-inflammatory factors or the downregulation of
proinflammatory factors. In addition, MSCs may also suppress immune reactions via direct cell
contact.
Mesenchymal stem cells (MSCs) are activated by inflammatory mediators and release paracrine
factors and microvesicles in the bloodstream. These molecules reach the site of injury and, together
with MSCs previously recruited, modulate the progression of inflammation and facilitate tissue repair
within the brain. (3)
Current limitations
More research is needed to promote accelerated approval to validate the use of stem cell therapy for
Alzheimer's and mild dementia and to better understand its mechanisms of action. The Food and Drug
Administration (FDA) has not yet approved stem cell therapy as a treatment for Alzheimer's, and the
cost of this therapy may be a barrier for some patients. A healthy lifestyle, including regular exercise, a
balanced diet, and engaging in mentally stimulating activities, is beneficial for brain health and may
help to reduce the risk of developing Alzheimer's and other forms of dementia.[2]
Stem cells can improve functional recovery for Alzheimer's
Choi continues to state that the transplantation of stem cells has been able to improve functional
recovery for Alzheimer’s Disease. Mesenchymal Stem Cells (MSCs) could promote survival, increase
metabolic activity and help to rescue the AD cell model in vitro. Chi also states that the transplantation
of Mesenchymal Stem Cells (MSCs) has reduced Aβ deposition, improved memory, and alleviated
AD pathology in AD mouse models.
What makes stem cell therapy for Alzheimer’s so exciting is its possibility to halt the progression of
the disease and regenerate damaged neurons rather than just slowing it or managing symptoms.
Stem cell research for Alzheimer's Disease
Stem cell research has proven the safety of using mesenchymal stem cells to treat various conditions.
(4) The efficacy of stem cell therapy ranges as per condition; however, the literature is well on its way
to solidifying the effectiveness of treatment for certain conditions, Alzheimer's being one of them.
What is Alzheimer's disease
Alzheimer's is a progressive neurodegenerative disorder affecting memory, thinking, and behavior. It
is the most common cause of dementia, accounting for up to 70% of all cases. The disease is
characterized by the accumulation of beta-amyloid plaques and tau protein tangles in the brain, leading
to brain cell death and a progressive decline in cognitive function.
As the disease progresses, individuals with Alzheimer's may experience memory loss, difficulty with
language and communication, mood and personality changes, and eventually lose their ability to

1080 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
CAJMNS Volume: 04 Issue: 03 | May-Jun 2023
perform daily activities. Currently, there is no cure for Alzheimer's disease, but treatments are
available to manage symptoms and slow the progression of the disease.[3]
Discussion
What are the symptoms of Alzheimer’s Disease
The symptoms of Alzheimer’s Disease can become much more debilitating than simple memory loss.
According to the Mayo Clinic (1), people with Alzheimer’s may:
 Forget conversations, appointments, and names
 Get lost easier, lose their sense of direction
 Have difficulty finding the correct word to associate with a familiar object
 Repeat questions and statements
 Eventually, forget the names of friends and family members
 Changes in personality or behavior
These symptoms can significantly impair one’s ability to function at work or home, resulting in a loss
of independence or self-sufficiency.
Causes of Alzheimer’s Disease
A combination of genetic, lifestyle, and environmental factors may cause the onset of Alzheimer’s.
The disease's exact cause is unknown, but scientists do know that Alzheimer’s coincides with the
brain’s inability to function normally. [4]
Alzheimer’s may also be characterized by an increase in amyloid and tau protein buildup within the
brain; though this is a symptom of Alzheimer’s, it has not been proven to cause the disease
The prevalence of Alzheimer's disease
Alzheimer's disease affects millions worldwide. Early Alzheimer's disease symptoms are characterized
by mild cognitive impairment, memory loss, difficulty with language, disorientation, mood swings,
and other mental and behavioral symptoms. Alzheimer's is the most common cause of dementia and
can profoundly impact the lives of affected individuals and their families.
Current research suggests a combination of age-related changes in the brain and genetic,
environmental, and lifestyle factors may contribute to developing Alzheimer's disease. The
significance of these factors in raising or lowering the risk of Alzheimer's may vary from individual to
individual.
How is Alzheimer's disease treated currently
Alzheimer's disease is currently treated with various medications that aim to alleviate the symptoms of
the disease, but there is no cure. Two classes of drugs are commonly used to treat Alzheimer's:
cholinesterase inhibitors and NMDA receptor antagonists. Cholinesterase inhibitors, such as
donepezil, rivastigmine, and galantamine, are designed to slow the breakdown of acetylcholine, a
neurotransmitter involved in memory and learning. NMDA receptor antagonists, such as memantine,
regulate the activity of glutamate, another neurotransmitter involved in memory and learning.[5]
These medications can help improve cognitive function and treat symptoms such as memory loss,
confusion, and agitation, but they do not halt the progression of the disease. Additionally, they may
cause side effects such as nausea, vomiting, and diarrhea and may interact with other medications.
In addition to medications, lifestyle changes such as regular exercise, a healthy diet, and engaging in
mentally stimulating activities benefit brain health. They may help slow the disease's progression.
Caregiver support and managing behavioral symptoms like aggression and wandering are essential to
Alzheimer's disease management.[20]

1081 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
CAJMNS Volume: 04 Issue: 03 | May-Jun 2023
Is there a cure for Alzheimer's disease
Currently, there is no cure for Alzheimer's disease. While medications and lifestyle changes can help
to alleviate the symptoms of the disease and improve the quality of life for those affected, they do not
halt the progression of the disease. There is ongoing research to understand the underlying causes of
Alzheimer's better and to develop new treatments that may be more effective in treating the disease.
Stem cell therapy is one potential avenue of research explored as a possible treatment for Alzheimer's,
but more research is needed to validate its long-term effectiveness.[19]
Stem cell therapy as a new treatment for Alzheimer's
In recent years, stem cell therapy has emerged as a promising potential treatment for Alzheimer's.
Stem cells can differentiate into various types of cells, including brain cells, potentially replacing
damaged cells and improving cognitive function. As such, stem cell therapy is being explored to slow
or halt the progression of Alzheimer's and potentially even reverse some of its effects.[6]
Clinical trials and research suggests stem cell therapy for Alzheimer's may be beneficial
Mesenchymal stem cells (MSCs) are a type of stem cell that can differentiate into multiple cell types,
including bone, cartilage, and fat cells. They are found in several tissues in the body, including bone
marrow, adipose tissue, and umbilical cord tissue, and they can be isolated and cultured in the
laboratory for therapeutic use.
"In the context of Alzheimer's disease, MSCs are being investigated as a potential treatment option due
to their ability to promote tissue repair and reduce inflammation in the brain. Many mechanisms have
also been proposed, including reduction of Aβ plaques, BACE, and tau hyperphosphorylation, reversal
of microglial inflammation, and promotion of anti-inflammatory cytokines. Immunomodulatory and
anti-inflammatory effects have been observed by upregulating neuroprotection and downregulating
proinflammatory cytokines. Another meaningful way for MSCs to participate in tissue repair is the
secretion of extracellular vesicles and microvesicles, which have been widely explored. (5)"
Studies have shown that MSCs can help to reduce the buildup of Aβ plaques in the brain and improve
cognitive function in animal models of Alzheimer's disease. MSCs can do this by secreting anti-
inflammatory and anti-oxidant molecules that can reduce inflammation and oxidative stress in the
brain. Also, MSCs can differentiate into neurons, which can help replace damaged or lost nerve cells
in the brain.[7]
While more research is needed to validate the use of MSCs as a treatment for Alzheimer's disease,
early studies have shown promising results. They suggest that this approach may hold potential as a
new therapeutic option for this debilitating disease.[18]
The Benefits of stem cell therapy for Alzheimer's disease
Mesenchymal stem cell (MSC) therapy for Alzheimer's disease holds several potential benefits,
including:
1. Reduction of inflammation: MSCs can secrete anti-inflammatory molecules, which can help
reduce brain inflammation (neuroinflammation). Chronic inflammation is associated with the
development and progression of Alzheimer's disease, and reducing inflammation can help to slow
the disease's progression.
2. Stimulation of tissue repair: MSCs can differentiate into different cell types, including neuron-like
cells, which can help to replace damaged or lost nerve cells in the brain. This process can
potentially help to restore cognitive function in people with Alzheimer's disease.
3. Reduction of amyloid plaque buildup: Studies have shown that MSCs can reduce the accumulation
of amyloid beta protein, a hallmark of Alzheimer's disease. This can potentially slow the disease's
progression and improve cognitive function.

1082 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
CAJMNS Volume: 04 Issue: 03 | May-Jun 2023
4. Minimal risk of rejection: MSCs are known to have low immunogenicity, which means they are
less likely to be rejected by the recipient's immune system. This can make MSC therapy a safe and
viable treatment option for Alzheimer's disease.[8]
Results
Importance of conducting clinical trials
It is essential to conduct clinical trials to determine the safety and efficacy of mesenchymal stem cell
(MSC) therapy for Alzheimer's disease before it can be considered a viable treatment option. While
early studies have shown promising results, more research is needed to validate the safety and efficacy
of this therapy.
Clinical trials are essential for determining the safety and efficacy of any new treatment. MSC therapy
is no exception, and it is necessary to understand its potential risks and benefits before it can be used
to treat people with Alzheimer's disease.
In clinical trials, the safety of MSC therapy will be closely monitored to ensure no adverse effects on
the recipient's health. The efficacy of the treatment will also be measured to determine if it positively
impacts cognitive function and other symptoms of Alzheimer's disease.
Moreover, clinical trials will also help to optimize the dosage, route of administration, and timing of
MSC therapy to maximize its effectiveness while minimizing the risk of adverse effects.In summary,
conducting clinical trials is crucial to validate the safety and efficacy of MSC therapy for Alzheimer's
disease. Only through rigorous testing and analysis can we determine whether this therapy can be
considered a viable treatment option for people with Alzheimer's disease.
The impact that successful clinical trials could have on the future of Alzheimer's disease treatment and
public health[9]
Successful clinical trials of mesenchymal stem cell (MSC) therapy for Alzheimer's disease could
significantly impact the future of Alzheimer's disease treatment and public health.
If clinical trials demonstrate that MSC therapy is a safe and effective treatment option for Alzheimer's,
it could provide a new and promising avenue for treating the disease. MSC therapy can potentially
address some underlying causes of Alzheimer's disease, including inflammation, tissue damage, and
amyloid plaque buildup.[10]
Successful MSC therapy could improve the quality of life of people with Alzheimer's disease by
slowing or halting the progression of the disease, potentially improving cognitive function, and
reducing symptoms.
Moreover, successful MSC therapy could also have significant public health implications. Alzheimer's
disease is a major public health issue affecting millions worldwide, and its prevalence is expected to
increase in the coming years. MSC therapy can potentially reduce the burden of Alzheimer's disease
on healthcare systems, caregivers, and the economy as a whole.
Additionally, suppose MSC therapy proves to be a safe and effective treatment for Alzheimer's
disease. In that case, it could open up new avenues of research for other neurodegenerative disorders
and other conditions involving tissue damage and inflammation.
Does stem cell therapy work for Alzheimer's
Stem cell therapy has emerged as a promising treatment for Alzheimer's disease, with numerous
studies suggesting that it can improve cognitive function and reduce the symptoms of the disease.
Stem cell therapy has the potential to repair damaged brain tissue and reduce inflammation, which are
two of the significant contributors to the development and progression of Alzheimer's disease. Stem

1083 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
CAJMNS Volume: 04 Issue: 03 | May-Jun 2023
cells can also release growth factors that help to promote the growth of new brain cells, which can help
to restore cognitive function.[11,12]
Recent studies have reported positive outcomes for stem cell therapy for Alzheimer's disease. For
instance, one study published in the Journal of Alzheimer's Disease reported that administering
mesenchymal stem cells (MSCs) improved cognitive function and reduced amyloid beta plaques in a
mouse model of Alzheimer's disease.
Another study published in Stem Cells Translational Medicine reported that MSC therapy improved
cognitive function and reduced inflammation in a small group of people with Alzheimer's.These
findings suggest that stem cell therapy could be a game-changer in the treatment of Alzheimer's
disease, with the potential to slow or even halt the progression of the disease.
Advantages of Stem Cell Therapy for Alzheimer's
Stem cell therapy has shown promise in treating Alzheimer's disease by addressing the underlying
causes of the disease, such as reducing the number of amyloid deposits and beta-amyloid plaques in
the brain, which is thought to play a role in the cognitive decline associated with Alzheimer's. Stem
cell therapy may slow down or even halt the progression of the disease and improve cognitive
function, daily life, and quality of life for those affected by Alzheimer's.
Common Side Effects of Stem Cell Therapy
While stem cell therapy is generally considered safe, there can be some common side effects, such as
swelling, headaches, and fatigue. These side effects are usually mild and temporary, and the benefits
of stem cell therapy may outweigh the risks for some individuals.[13]
Risks and Drawbacks of Stem Cell Therapy as a Treatment for Alzheimer's
Despite the potential benefits, stem cell therapy for Alzheimer's is still considered experimental, and
more research is needed to validate its use as a treatment. The cost of stem cell therapy can also be a
drawback, as it is often more expensive than other treatments for Alzheimer's. Stem cell therapy may
not work for everyone, and its effectiveness may vary depending on the individual and the stage of the
disease. Discussing the benefits and risks with a healthcare provider and considering other options
before initiating treatment is essential.[14]
Conclusions
In conclusion, Alzheimer's disease is a complex neurodegenerative disorder that affects millions of
people worldwide, and it is a severe condition that requires ongoing research and treatment. While
current therapies for early-stage Alzheimer's can help manage symptoms and improve quality of life,
there is still no cure.[15]
However, stem cell therapy shows promise as a potential treatment for Alzheimer's, with mesenchymal
stem cells being a current research focus. Clinical trials are ongoing to determine the safety and
efficacy of this treatment. The results of these trials will be significant in further understanding the
disease process and identifying new targets for therapy. Stem cells as an Alzheimer's treatment are
currently in a preclinical stage but have shown the ability to slow functional decline, in addition,
monoclonal antibodies and other pharmaceuticals that target beta-amyloid and reduce amyloid
deposits in the brain are being developed and may offer new options for treating Alzheimer's disease.
Preclinical and clinical research in this area is ongoing, and pharmaceutical companies are working to
gather the necessary safety and effectiveness data to bring new treatments to market.[16]
As research continues, family members and caregivers need to be aware of the first symptoms of
Alzheimer's disease and seek medical attention for their loved ones. Early intervention can help slow
the disease's clinical decline and improve the quality of life for those affected. Treatments are
available to manage symptoms such as memory problems and agitation in moderate to severe stages of

1084 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
CAJMNS Volume: 04 Issue: 03 | May-Jun 2023
the disease. With continued research and a better understanding of the underlying mechanisms of
Alzheimer's disease, we may one day find a cure and improve the lives of millions worldwide.[17]
References
1. Knopman DS, Amieva H, Petersen RC, et al. (May 2021). "Alzheimer disease". Nat Rev Dis
Primers. 7 (1): 33. doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
2. "Dementia Fact sheet". World Health Organization. September 2020.
3. Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (May 2005). "Alzheimer disease and
mortality: a 15-year epidemiological study". Archives of Neurology. 62 (5): 779–784.
doi:10.1001/archneur.62.5.779. PMID 15883266.
4. Mendez MF (November 2012). "Early-onset Alzheimer's disease: nonamnestic subtypes and type
2 AD". Archives of Medical Research. 43 (8): 677–685. doi:10.1016/j.arcmed.2012.11.009. PMC
3532551. PMID 23178565.
5. "Dementia diagnosis and assessment" (PDF). National Institute for Health and Care Excellence
(NICE). Archived from the original (PDF) on 5 December 2014. Retrieved 30 November 2014.
6. Gomperts SN (April 2016). "Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson
Disease Dementia". Continuum (Review). 22 (2 Dementia): 435–463.
doi:10.1212/CON.0000000000000309. PMC 5390937. PMID 27042903.
7. Lott IT, Head E (March 2019). "Dementia in Down syndrome: unique insights for Alzheimer
disease research". Nat Rev Neurol. 15 (3): 135–147. doi:10.1038/s41582-018-0132-6. PMC
8061428. PMID 30733618.
8. Commission de la transparence (June 2012). "Drugs for Alzheimer's disease: best avoided. No
therapeutic advantage" [Drugs for Alzheimer's disease: best avoided. No therapeutic advantage].
Prescrire International. 21 (128): 150. PMID 22822592.
9. Querfurth HW, LaFerla FM (January 2010). "Alzheimer's disease". The New England Journal of
Medicine. 362 (4): 329–344. doi:10.1056/NEJMra0909142. PMID 20107219. S2CID 205115756.
10. Breijyeh Z, Karaman R (December 2020). "Comprehensive Review on Alzheimer's Disease:
Causes and Treatment". Molecules (Review). 25 (24): 5789. doi:10.3390/molecules25245789.
PMC 7764106. PMID 33302541.
11. Simon RP, Greenberg DA, Aminoff MJ (2018). Clinical neurology (Tenth ed.). [New York]:
McGraw Hill. p. 111. ISBN 978-1-259-86173-4. OCLC 1012400314.
12. Burns A, Iliffe S (February 2009). "Alzheimer's disease". BMJ. 338: b158. doi:10.1136/bmj.b158.
PMID 19196745. S2CID 8570146.
13. "Alzheimer's Disease Fact Sheet". National Institute on Aging. Retrieved 25 January 2021.
14. Todd S, Barr S, Roberts M, Passmore AP (November 2013). "Survival in dementia and predictors
of mortality: a review". International Journal of Geriatric Psychiatry. 28 (11): 1109–1124.
doi:10.1002/gps.3946. PMID 23526458. S2CID 25445595.
15. Long JM, Holtzman DM (October 2019). "Alzheimer Disease: An Update on Pathobiology and
Treatment Strategies". Cell. 179 (2): 312–339. doi:10.1016/j.cell.2019.09.001. PMC 6778042.
PMID 31564456.
16. "Study reveals how APOE4 gene may increase risk for dementia". National Institute on Aging. 16
March 2021. Retrieved 17 March 2021.

1085 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
CAJMNS Volume: 04 Issue: 03 | May-Jun 2023
17. Hsu D, Marshall GA (2017). "Primary and secondary prevention trials in Alzheimer disease:
looking back, moving forward". Curr Alzheimer Res. 14 (4): 426–440.
doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
18. Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J (July 2007). "Systematic
review of information and support interventions for caregivers of people with dementia". BMC
Geriatrics. 7: 18. doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
19. Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (April 2015). "Exercise programs for
people with dementia". The Cochrane Database of Systematic Reviews (Submitted manuscript).
132 (4): CD006489. doi:10.1002/14651858.CD006489.pub4. PMC 9426996. PMID 25874613.
20. National Institute for Health and Clinical Excellence. "Low-dose antipsychotics in people with
dementia". National Institute for Health and Care Excellence (NICE). Archived from the original
on 5 December 2014. Retrieved 29 November 2014.
21. "Information for Healthcare Professionals: Conventional Antipsychotics". US Food and Drug
Administration. 16 June 2008. Archived from the original on 29 November 2014. Retrieved 29
November 2014.

1086 Published by “ CENTRAL ASIAN STUDIES" http://www.centralasianstudies.org

Copyright (c) 2023 Author (s). This is an open-access article distributed under the terms of Creative Commons
Attribution License (CC BY).To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/